It’s a step forward. Just as importantly, it will spur other research as they investigate the limits of this test and try to explain why it works or, possibly in some cases, doesn’t.
Femkemilene on
Really cool, but it’s not the first small-scale study that has found a biomarker. The next step should be a large-scale study comparing these three or four options, including in similarly parenting diseases.
Most pharma companies ignore diseases without a biomarker as too risky, so any biomarker research funded by government can crowd in investment
Don_Ford on
These tests are more of a way to limit a diagnosis than to allow one.
People with ME/CFS are easily identifiable by symptoms.
Leave A Reply
Du musst angemeldet sein, um einen Kommentar abzugeben.
3 Kommentare
It’s a step forward. Just as importantly, it will spur other research as they investigate the limits of this test and try to explain why it works or, possibly in some cases, doesn’t.
Really cool, but it’s not the first small-scale study that has found a biomarker. The next step should be a large-scale study comparing these three or four options, including in similarly parenting diseases.
Most pharma companies ignore diseases without a biomarker as too risky, so any biomarker research funded by government can crowd in investment
These tests are more of a way to limit a diagnosis than to allow one.
People with ME/CFS are easily identifiable by symptoms.